| Literature DB >> 33247011 |
Chen Huanan1, Li Sangsang2, Adwoa Nyantakyiwaa Amoah1, Bo Yacong3, Chen Xuejiao4, Shi Zhan5, Wan Guodong6, Huang Jian7, Shi Songhe8, Lyu Quanjun9,10.
Abstract
OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is one of the major causes of liver-related diseases but relationship between triglyceride glucose (TyG) and NAFLD in the elderly is not reported yet. In this study, we investigated the role of TyG index for predicting the incidence of NAFLD in the elderly. DESIGN ANDEntities:
Keywords: hepatobiliary disease; lipid disorders; public health
Mesh:
Substances:
Year: 2020 PMID: 33247011 PMCID: PMC7703442 DOI: 10.1136/bmjopen-2020-039804
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow chart for participants exclusions performed. HBs Ag, hepatitis B surface antigen; HCV Ab, hepatitis C virus antibody; NAFLD, non-alcoholic fatty liver disease.
Baseline characteristics of included participants according to the follow-up outcome
| Variables | No NAFLD (n=41 033) | NAFLD (n=5660) | P value |
| Men, n (%)* | 20 799 (50.69) | 2033 (35.92) | <0.001 |
| Age (years)† | 69.18±7.27 | 66.93±6.00 | <0.001 |
| Current smoking, n (%)* | 6846 (16.70) | 594 (10.51) | <0.001 |
| Exercise, n (%)* | 7865 (19.22) | 1131 (20.02) | <0.001 |
| Live alone, n (%)* | 8772 (21.38) | 1015 (17.93) | <0.001 |
| Diabetes, n (%)* | 5554 (13.54) | 1344 (23.75) | <0.001 |
| Hypertension, n (%)* | 15 945 (38.86) | 2952 (52.16) | <0.001 |
| WHtR† | 0.51±0.06 | 0.54±0.07 | <0.001 |
| BMI† | 23.62±2.85 | 26.02±3.10 | <0.001 |
| SBP (mm Hg)† | 132.62±19.38 | 135.32±19.76 | <0.001 |
| DBP (mm Hg)† | 78.92±10.34 | 80.91±10.33 | <0.001 |
| FPG (mmol/L)‡ | 5.20 (4.70 to 5.70) | 5.30 (4.80 to 5.93) | <0.001 |
| TC (mmol/L)‡ | 4.59 (4.01 to 5.21) | 4.69 (4.09 to 5.38) | <0.001 |
| TG (mmol/L)‡ | 1.10 (0.81 to 1.47) | 1.28 (0.90 to 1.77) | <0.001 |
| TB (μmol/L)‡ | 11.51 (8.60 to 14.10) | 11.30 (8.30 to 13.80) | <0.001 |
| ALT(U/L)‡ | 18.00 (13.00 to 24.50) | 18.60 (14.00 to 25.00) | <0.001 |
| AST(U/L)‡ | 21.80 (16.89 to 26.90) | 21.90 (16.89 to 27.00) | 0.892 |
| TyG‡ | 8.43±0.54 | 8.61±0.59 | <0.001 |
*n (%).
†Mean (SD).
‡Median (IQR).
ALT, alanine aminotransferase; AST, aspartate transaminase; BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; NAFLD, non-alcoholic fatty liver disease; SBP, systolic blood pressure; TB, total bilirubin; TC, total cholesterol; TG, triglyceride; TyG, triglyceride glucose; WHtR, waist-to-height ratio.
Relationship between TyG index and the risk of NAFLD
| TyG index | ||||
| N | Unadjusted | Model 1 | Model 2 | |
| As continuous | 50 037 | 1.697 (1.619 to1.779) | 1.577 (1.504 to 1.653) | 1.265 (1.200 to 1.334) |
| Quartile 1 | 12 556 | Reference | Reference | Reference |
| Quartile 2 | 12 458 | 1.056 (0.971 to 1.149) | 1.035 (0.951 to 1.126) | 0.980 (0.895 to 1.073) |
| Quartile 3 | 12 522 | 1.300 (1.200 to 1.408) | 1.259 (1.162 to 1.364) | 1.090 (0.999 to 1.190) |
| Quartile 4 | 12 501 | 1.972 (1.832 to 2.123) | 1.783 (1.655 to 1.920) | 1.314 (1.234 to 1.457) |
| P for trend | <0.001 | <0.001 | <0.001 | |
Quartile 1≤8.11; 8.12
Model 1: Adjusted age and sex.
Model 2: Model 1 plus living alone, current smoking, exercise, waist-to-height ratio, systolic blood pressure, diastolic blood pressure, alanine aminotransferase, aspartate aminotransferase, total bilirubin, total cholesterol and diabetes.
NAFLD, non-alcoholic fatty liver disease; TyG, triglyceride glucose.
Figure 2ROC curves of baseline TyG to predict the incidence of NAFLD among those aged 60 years or older. NAFLD, non-alcoholic fatty liver disease; ROC, receiver operating characteristic; TyG, triglyceride glucose.
Figure 3Restricted cubic spline graph of risk of TyG index and the development of NAFLD. Multivariate adjusted HRs of NAFLD increased during follow-up when the baseline level of TyG index was 8.63 and above. Adjusted variables including age, sex (not for sex subgroup analysis), living alone, current smoking, exercise, waist-to-height ratio, systolic blood pressure, diastolic blood pressure, alanine aminotransferase, aspartate aminotransferase, total bilirubin and total cholesterol. TyG, triglyceride glucose; NAFLD, non-alcoholic fatty liver disease.
Mediation analysis of the relationship between TyG index and NAFLD by WHtR
| Effect | HR (95% CI) |
| Total effect | 1.476 (1.437 to 1.517) |
| Direct effect | 1.463 (1.423 to 1.503) |
| Indirect effect | 1.009 (1.006 to 1.011) |
NAFLD, non-alcoholic fatty liver disease; TyG, triglyceride glucose; WHtR, waist-to-height ratio.
Figure 4The mediate effect of TyG index on WHtR and NAFLD. NAFLD, non-alcoholic fatty liver disease; TyG, triglyceride glucose; WHtR, waist-to-height ratio.